Help
Posted Wed, Nov, 02,2011
The Editor in Chief of Clinical Medical Insights: Oncology, Dr William C S Cho, has awarded an endorsement to 'Tyrosine Kinase Inhibitors in the Treatment of Advanced Renal Cell Carcinoma: Focus on Pazopanib'
In the endorsement the Editor in Chief writes:
This review is informative on the hot topic of TKI therapies for renal cell carcinoma
To read more visit the article now: Tyrosine Kinase Inhibitors in the Treatment of Advanced Renal Cell Carcinoma: Focus on Pazopanib
Posted in: Editor in Chief Endorsed Articles
News Categories
Thu 08 Oct, 2015
Published This Week (5th - 9th October)Thu 08 Oct, 2015
Biomarker Insights Paper Endorsed by Editor in ChiefWed 07 Oct, 2015
Interview with Professor Jamie DaviesI enjoyed doing the recent peer review and after reading the article felt that I was witnessing a new way of thinking and examining issues. Thank you for allowing me to be a part of this exciting venture into discovery.
Facebook Google+ Twitter
Pinterest Tumblr YouTube